Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.00%
)
US TECH 100
26,271.60
(
-1.12%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
104.59
(
2.42%
)
Bitcoin
76,115.53
(
-1.62%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: cjgaddy post# 250776

Friday, 01/29/2016 10:27:18 AM

Friday, January 29, 2016 10:27:18 AM

Post# of 347009
CJ great post to keep us all updated! I think I have said it before but you were certainly #1 the reason why I am here today and never left. The INTRO is so massive and not for the weak at heart to dive into and try to learn about Peregrine. I don't think many can see the technology that will seep out of this paradigm shift....and am looking forward to see it unfold.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote